Mycamine Approval History
- FDA approved: Yes (First approved March 16th, 2005)
- Brand name: Mycamine
- Generic name: micafungin sodium
- Dosage form: for Injection
- Company: Fujisawa Healthcare, Inc.
- Treatment for: Esophageal Candidiasis, Fungal Infection Prophylaxis, Candidemia
Mycamine (micafungin sodium) is an echinocandin antifungal agent used for the prophylaxis of Candida infections in patients undergoing hematopoietic stem cell transplantation, for the treatment of esophageal candidiasis and candidemia.
Development History and FDA Approval Process for Mycamine
Disclaimer: Every effort has been made to ensure that the information provided here is accurate, up-to-date and complete, but no guarantee is made to that effect. Drug information contained herein may be time sensitive. This information has been compiled for use by healthcare practitioners and consumers in the United States. The absence of a warning for a given drug or combination thereof in no way should be construed to indicate that the drug or combination is safe, effective or appropriate for any given patient. If you have questions about the substances you are taking, check with your doctor, nurse or pharmacist.